ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Grant, contract Awards Held Up By Impasse On Appropriations

October 14, 1977

In Brief: House Passes FY ’77 Money Bill, But Veto Seems Likely; NIH Relaxes Moonlighting Rule

August 20, 1976

NIAMDD Scientists Find Virus Gene Causes, Continues Cancer

May 9, 1975

FDA Guidance for Public Comment at Advisory Committee Meetings

December 10, 2010

In Brief: ACS to support $2 Billion NCI Budget; NCAB Backs Minority Enhancement Core Supplements

February 19, 1988

Breast Cancer Rates Decline Most for Affluent White Women

February 26, 2010